Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Michael C. Woodward who wrote (64)	11/5/1997 10:22:00 AM
From: John Swingle	Read Replies (3) \| Respond to of 534

I have followed this company in the past and recently became interested in it again with the news that Group Health was using the system for flu shots at local area supermarkets. I used to think that the Biojector delivered relatively painless injections and that was why it was ideal for pediatrics. A friend recently had a flu shot and said it much more painful than a needle. The nurse made the comment that the shot was needleless not painless leading me to believe that his was not an isolated experience. I am thinking about buying back in here. Anyone had similar experience with the Biojector? John

To: Michael C. Woodward who wrote (64)	11/5/1997 10:32:00 AM
From: Keith R.	Read Replies (2) \| Respond to of 534

A few thoughts re: Bioject: Besides the obvious benefit of Elan making a large investment in the company, there is one large side benefit. Prior to this deal, BJCT had been talking with no less than 5 major pharmaceutical Co.'s (i.e. N. Amer. Vaccines, JNJ, Teva and others). re: deals that would bundle the Biojector with various proprietary vaccines and drugs. The biggest impediment to these deals being consummated were: 1)the financial condition of BJCT and , 2) more importantly, the lack of a "pre-fill" technology as nobody wanted to be a trailblazer, helping BJCT to develop this technology. Now that both of these have been solved with the Elan deal, one or more of these large Co.'s could come on board in the fairly near term. Flu shot programs, include Walmart appear to be doing well. At least four new states or municipalities will be signed in the near term for immunization programs. BJCT will be making a presentation to Hambricht & Quist Preferred Technology as well as a group of large investors in Boston on Thursday and Friday 11/7-11/8. There should be some interest generated from this meeting. A friend/investment advisor of mine has an associate who will be attending this meeting. Good luck,